메뉴 건너뛰기




Volumn 51, Issue 1306, 2009, Pages 13-14

PPI interactions with clopidogrel revisited
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYTOCHROME P450 2C19; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NIZATIDINE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; ANTITHROMBOCYTIC AGENT; CYP2C19 PROTEIN, HUMAN; DRUG DERIVATIVE; TICLOPIDINE; UNSPECIFIC MONOOXYGENASE;

EID: 61849088896     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey
Times cited : (9)

References (7)
  • 1
    • 54049118496 scopus 로고    scopus 로고
    • ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
    • DL Bhatt et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2008; 52:1502.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 1502
    • Bhatt, D.L.1
  • 2
    • 58149383868 scopus 로고    scopus 로고
    • PPI interactions with clopidogrel
    • PPI interactions with clopidogrel. Med Lett Drugs Ther 2009; 51:2.
    • (2009) Med Lett Drugs Ther , vol.51 , pp. 2
  • 3
    • 58749094444 scopus 로고    scopus 로고
    • Cytochrome P-450 polymorphisms and response to clopidogrel
    • JL Mega et al. Cytochrome P-450 polymorphisms and response to clopidogrel. N Engl J Med 2009; 360:354.
    • (2009) N Engl J Med , vol.360 , pp. 354
    • Mega, J.L.1
  • 4
    • 58749090547 scopus 로고    scopus 로고
    • Genetic determinants of response to clopidogrel and cardiovascular events
    • T Simon et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009; 360:363.
    • (2009) N Engl J Med , vol.360 , pp. 363
    • Simon, T.1
  • 5
    • 58249135635 scopus 로고    scopus 로고
    • Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: A cohort study
    • J-P Collet et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 2009; 373:309.
    • (2009) Lancet , vol.373 , pp. 309
    • Collet, J.-P.1
  • 6
    • 3242676832 scopus 로고    scopus 로고
    • Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities
    • XQ Li et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos 2004; 32:821.
    • (2004) Drug Metab Dispos , vol.32 , pp. 821
    • Li, X.Q.1
  • 7
    • 62649164844 scopus 로고    scopus 로고
    • A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
    • epub
    • DN Juurlink et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2008; 180. epub.
    • (2008) CMAJ , vol.180
    • Juurlink, D.N.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.